+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Women's Health Therapeutics Market - Global Forecast 2026-2032- Product Image
Women's Health Therapeutics Market - Global Forecast 2026-2032- Product Image
New

Women's Health Therapeutics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5666342
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The women’s health therapeutics market is undergoing significant transformation, driven by advancements in clinical science, evolving care models, and dynamic commercial pressures. Senior executives require actionable intelligence to navigate this shifting landscape and position their organizations for success.

Market Snapshot: Women’s Health Therapeutics Market

The Women’s Health Therapeutics Market grew from USD 80.11 billion in 2025 to USD 88.88 billion in 2026. With a projected CAGR of 11.15%, the market is forecast to reach USD 167.92 billion by 2032. Growth is shaped by breakthroughs in targeted therapies, greater adoption of digital tools, and more complex payer and regulatory environments as organizations target oncology, reproductive health, gynecology, menopause, and bone health.

Scope & Segmentation

This analysis encompasses all major therapeutic areas, technology classes, and commercial channels relevant to women’s health therapeutics, supported by regional insights.

  • Therapeutic Focus Areas: Includes cancer therapies (notably breast, cervical, endometrial, ovarian), contraceptives (barrier, implant, injectable, IUD, pill, sterilization), gynecological disorders (endometriosis, pelvic inflammatory disease, polycystic ovary syndrome, uterine fibroids), menopausal therapies (botanical supplements, hormone replacement, nonhormonal therapies), and osteoporosis.
  • Product Modalities: Spans biologics (monoclonal antibodies, recombinant proteins, vaccines), devices (diagnostic, monitoring, therapeutic), and drugs (branded, generic).
  • Distribution Channels: Addresses drug stores, hospital pharmacy, online pharmacy, and retail pharmacy, impacting how therapies are accessed and managed.
  • End-User Settings: Incorporates hospitals, clinics, homecare, and specialty centers, reflecting distinct procurement, expertise, and reimbursement priorities.
  • Regional Coverage: Evaluates the Americas, Europe, Middle East & Africa, and Asia-Pacific, each with unique regulatory pathways and commercialization imperatives.

Key Takeaways

  • Scientific innovation, particularly in biologics and targeted oncology, is redefining treatment paradigms and clinical development strategies.
  • Digital health integration and decentralized care models are extending reach, improving adherence, and supporting real-world data capture that informs both regulatory and payer decisions.
  • Stakeholder demands for improved outcomes, safety, and equitable access are raising requirements for clinical evidence and commercial engagement.
  • Manufacturing and supply chain agility have become essential, with companies reevaluating sourcing, supplier diversification, and localized production to respond to policy shifts and mitigate operational risk.
  • Commercial strategies now require early market access planning, robust channel engagement models, and alignment with increasingly outcomes-focused payer frameworks.

Tariff Impact: U.S. Trade Measures on Women’s Health Therapeutics

In 2025, new U.S. tariffs have significant implications for supply chains, procurement, and launch economics across the women’s health therapeutics value chain. These measures increase costs on imported active ingredients, biologics materials, and device components, prompting manufacturers to explore supplier diversification and nearshoring options. Health system purchasers are adapting procurement strategies to manage cost fluctuations and mitigate lead-time risks, forcing tighter alignment between supply-chain and commercial teams. For emerging therapies and diagnostic technologies, tariffs intensify the impact of limited-scale production, increasing the necessity for holistic market access planning that considers total cost of ownership.

Regulators and payers are monitoring these developments, as cost adjustments can shift formulary positioning and negotiation leverage. Scenario planning and contingency strategies are now critical to safeguard product availability and sustain commercial traction during policy changes.

Methodology & Data Sources

This report integrates qualitative expert interviews, systematic literature reviews, and regulatory analyses for robust, scenario-driven insights. Extensive primary interviews with clinicians, payers, and commercial leaders were combined with secondary research from peer-reviewed publications, regulatory documentation, and clinical-trial registries. Findings were validated through sensitivity analyses and scenario-based stress testing to ensure reliability for strategic planning.

Why This Report Matters

  • Enables senior leaders to anticipate and respond to major market inflection points, with in-depth coverage of regulatory, technological, and supply chain trends.
  • Supports clinical and commercial decision makers in aligning R&D, market access, and operational strategies to unique regional and channel conditions.
  • Offers actionable recommendations, facilitating effective investments and partnerships to enhance adoption, reduce access risk, and optimize long-term value.

Conclusion

Effective navigation of the women’s health therapeutics market now demands integrated, evidence-driven, and resilient strategies. This report offers the insights needed to align clinical innovation with commercial reality and secure enduring market access.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Women's Health Therapeutics Market, by Therapeutic Area
8.1. Cancer Therapies
8.1.1. Breast Cancer
8.1.1.1. Her2 Positive
8.1.1.2. Hormone Receptor Positive
8.1.1.3. Triple Negative
8.1.2. Cervical Cancer
8.1.3. Endometrial Cancer
8.1.4. Ovarian Cancer
8.2. Contraceptives
8.2.1. Barrier Methods
8.2.2. Implant
8.2.3. Injectable
8.2.4. Iud
8.2.5. Pill
8.2.6. Sterilization
8.3. Gynecological Disorders
8.3.1. Endometriosis
8.3.2. Pelvic Inflammatory Disease
8.3.3. Polycystic Ovary Syndrome
8.3.4. Uterine Fibroids
8.4. Menopausal Therapies
8.4.1. Botanical Supplements
8.4.2. Hormone Replacement Therapy
8.4.2.1. Estrogen
8.4.2.2. Estrogen Plus Progestin
8.4.2.3. Tibolone
8.4.3. Nonhormonal Therapies
8.5. Osteoporosis
8.5.1. Bisphosphonates
8.5.2. Denosumab
8.5.3. Pth Analogues
8.5.4. Serms
9. Women's Health Therapeutics Market, by Product Type
9.1. Biologics
9.1.1. Monoclonal Antibodies
9.1.2. Recombinant Proteins
9.1.3. Vaccines
9.2. Devices
9.2.1. Diagnostic Devices
9.2.2. Monitoring Devices
9.2.3. Therapeutic Devices
9.3. Drugs
9.3.1. Branded
9.3.2. Generic
10. Women's Health Therapeutics Market, by End-User
10.1. Clinics
10.2. Homecare
10.3. Hospitals
10.4. Specialty Centers
11. Women's Health Therapeutics Market, by Distribution Channel
11.1. Drug Stores
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Women's Health Therapeutics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Women's Health Therapeutics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Women's Health Therapeutics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Women's Health Therapeutics Market
16. China Women's Health Therapeutics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. AbbVie Inc.
17.7. Amgen Inc.
17.8. AstraZeneca PLC
17.9. Baxter International Inc.
17.10. Biogen Inc.
17.11. Boehringer Ingelheim International GmbH
17.12. Bristol-Myers Squibb Company
17.13. Chiesi Farmaceutici S.p.A.
17.14. Cipla Limited
17.15. Daiichi Sankyo Co., Ltd.
17.16. Dr. Reddy’s Laboratories Ltd.
17.17. Eagle Pharmaceuticals, Inc.
17.18. Eli Lilly and Company
17.19. EVER Pharma Jena GmbH
17.20. F. Hoffmann-La Roche Ltd.
17.21. Ferring B.V.
17.22. Fresenius SE & Co. KGaA
17.23. Gilead Sciences, Inc.
17.24. GlaxoSmithKline PLC
17.25. Johnson & Johnson Services, Inc.
17.26. Merck & Co., Inc.
List of Figures
FIGURE 1. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HER2 POSITIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HER2 POSITIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HER2 POSITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE RECEPTOR POSITIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE RECEPTOR POSITIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE RECEPTOR POSITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TRIPLE NEGATIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TRIPLE NEGATIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TRIPLE NEGATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CERVICAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BARRIER METHODS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BARRIER METHODS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BARRIER METHODS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IMPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY IUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PILL, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PILL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PILL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ENDOMETRIOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PELVIC INFLAMMATORY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PELVIC INFLAMMATORY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PELVIC INFLAMMATORY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY POLYCYSTIC OVARY SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BOTANICAL SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN PLUS PROGESTIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN PLUS PROGESTIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ESTROGEN PLUS PROGESTIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TIBOLONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TIBOLONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TIBOLONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY NONHORMONAL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY NONHORMONAL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY NONHORMONAL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BISPHOSPHONATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BISPHOSPHONATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BISPHOSPHONATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DENOSUMAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DENOSUMAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DENOSUMAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PTH ANALOGUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PTH ANALOGUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PTH ANALOGUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SERMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SERMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SERMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 170. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 171. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 172. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 173. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 174. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 175. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 176. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 177. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 178. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 179. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 181. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 182. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 183. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 184. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 187. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 188. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 189. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 190. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 191. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 192. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 193. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 194. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 196. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 197. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 198. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 199. NORTH AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 202. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 203. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 204. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 205. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 206. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 207. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 208. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 209. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 211. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 212. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 213. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 214. LATIN AMERICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 232. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 233. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 234. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 235. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 236. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 237. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 238. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 239. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 241. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 242. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 243. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 244. EUROPE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 247. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 248. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 249. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 250. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 251. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 252. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 253. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 254. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 255. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 256. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 257. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 258. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 259. MIDDLE EAST WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 260. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 261. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 262. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 263. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 264. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 265. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 266. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 267. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 268. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 269. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 271. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 272. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 273. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 274. AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 275. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 276. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 277. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 278. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 279. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 280. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 281. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 282. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 283. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OSTEOPOROSIS, 2018-2032 (USD MILLION)
TABLE 284. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 286. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DEVICES, 2018-2032 (USD MILLION)
TABLE 287. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
TABLE 288. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 289. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 290. GLOBAL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 291. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 292. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 293. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CANCER THERAPIES, 2018-2032 (USD MILLION)
TABLE 294. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY BREAST CANCER, 2018-2032 (USD MILLION)
TABLE 295. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 296. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY GYNECOLOGICAL DISORDERS, 2018-2032 (USD MILLION)
TABLE 297. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY MENOPAUSAL THERAPIES, 2018-2032 (USD MILLION)
TABLE 298. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HORMONE REPLACEMENT THERAPY, 2018-2032 (USD MILLION)
TABLE 299. ASEAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY O

Companies Mentioned

The key companies profiled in this Women's Health Therapeutics market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Baxter International Inc.
  • Biogen Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Chiesi Farmaceutici S.p.A.
  • Cipla Limited
  • Daiichi Sankyo Co., Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Eagle Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • EVER Pharma Jena GmbH
  • F. Hoffmann-La Roche Ltd.
  • Ferring B.V.
  • Fresenius SE & Co. KGaA
  • Gilead Sciences, Inc.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 88.88 Billion
Forecasted Market Value ( USD ) by 2032 $ 167.92 Billion
Compound Annual Growth Rate11.1%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Women's Health Therapeutics - Global Strategic Business Report - Product Image

Women's Health Therapeutics - Global Strategic Business Report

  • Report
  • 189 Pages
  • Global
From
Womens Health Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Womens Health Therapeutics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 140 Pages
  • Global
From
Gynecology Drugs Market Report 2025 - Product Image

Gynecology Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Gynecology Drugs Market - Global Strategic Business Report - Product Image

Gynecology Drugs Market - Global Strategic Business Report

  • Report
  • 386 Pages
  • Global
From
Gynecology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Gynecology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From

About the Women Health Therapeutic Market

The Women Health Therapeutic market is a subset of the Women's Health industry, focusing on the development and delivery of treatments and therapies for women's health issues. This market includes a range of products and services, from pharmaceuticals and medical devices to lifestyle and wellness products. It also includes services such as health education, counseling, and support. The goal of the Women Health Therapeutic market is to improve the health and well-being of women by providing access to treatments and therapies that are tailored to their needs. Some of the companies in the Women Health Therapeutic market include Pfizer, Merck, Johnson & Johnson, Novartis, Bayer, and GlaxoSmithKline. These companies are involved in the development and delivery of treatments and therapies for women's health issues, as well as providing health education and support services. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.